ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 842

Interleukin 17 Receptor D (IL-17RD) Is Regulated By Pro-Inflammatory Cytokines and Plays a Role in the Development of Collagen-Induced Arthritis

M Molendijk1, A Otten-Mus2, P Asmawidjaja3, Dominique Baeten4 and Erik Lubberts5, 1Rheumatology, Erasmus MC, Rotterdam, Netherlands, 2Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Rheumatology and Clinical Immunology, AMC, Amsterdam, Netherlands, 5Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoimmunity, cytokines, inflammation and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S080 ACR Abstract: Cytokines & Cell Trafficking (840–845)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Interleukin-17 Receptor D (IL-17RD) otherwise known as similar expression of fibroblast growth factor genes (SEF) is often described as an inhibitor of multiple signaling cascades. IL-17RD is a member of the IL-17 receptor family. In contrast to the other IL-17 receptors, IL-17RA, -RB, -RC and -RE, little is known about the ligand and function of IL-17RD. We hypothesized that IL-17RD is a brake that needs to be removed in order to develop auto-immune arthritis. However, the functional role of IL-17RD in auto-immune arthritis is still unknown and is the purpose of this study.

Methods: Human synovial fibroblasts from Rheumatoid Arthritis (RA) patients were stimulated with tumor necrosis factor α (TNFα), interleukin 1 β (IL-1β) or IL-17A for multiple time points. IL-17RD expression levels were measured via qPCR. Collagen induced arthritis (CIA) was induced in IL-17RD knockout mice and wildtype littermates. At days 1 and 21, mice were immunized intradermally with chicken collagen type II in complete Freund’s adjuvant (CFA). Mice were scored 3 times a week for clinical disease defined as swollen joints with a maximum score of 8. Due to ethical reasons, mice were removed from the experiments when they reached a score of 6. CD4+ memory T cells, CD8+ memory T cells, CD19+ B cells and monocytes were isolated from WT spleens and analysed for IL-17RD expression. Blood neutrophil migration assays were performed in vitro using WT and IL-17RD deficient (IL-17RD KO) mouse synovial fibroblasts.

Results: We show that IL-17RD is regulated by pro-inflammatory cytokines and plays a role in the development of collagen-induced arthritis (CIA). IL-17RD expression was decreased in human synovial fibroblasts from rheumatoid arthritis (RA) patients upon stimulation with TNFα or IL-1β but not IL-17A. Interestingly, CIA incidence was significantly reduced in IL-17RD knockout (IL-17RD KO) mice compared to wildtype littermates (C57BL/6N) without affecting CIA severity in mice developing clinical manifest disease. Besides very low or absent IL-17RD expression in immune cells, no altered cytokine production was observed in LPS stimulated monocytes or αCD3 and αCD28 activated CD4+ T cells from IL-17RD KO mice versus WT controls. However, lower production of CXCL2 was detected by IL-17RD deficient synovial fibroblasts when stimulated with TNFα and IL-17A. Additionally, less neutrophils were attracted by these IL-17RD deficient synovial fibroblasts.

Conclusion: These data show the downregulation of baseline IL-17RD expression by pro-inflammatory cytokines in synovial fibroblasts and how IL-17RD deficiency reduces CIA incidence. This indicates that IL-17RD is likely a brake that is removed in an inflammatory environment but contradictorily lowers the chance of developing auto-immune arthritis.


Disclosure: M. Molendijk, None; A. Otten-Mus, None; P. Asmawidjaja, None; D. Baeten, None; E. Lubberts, None.

To cite this abstract in AMA style:

Molendijk M, Otten-Mus A, Asmawidjaja P, Baeten D, Lubberts E. Interleukin 17 Receptor D (IL-17RD) Is Regulated By Pro-Inflammatory Cytokines and Plays a Role in the Development of Collagen-Induced Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/interleukin-17-receptor-d-il-17rd-is-regulated-by-pro-inflammatory-cytokines-and-plays-a-role-in-the-development-of-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interleukin-17-receptor-d-il-17rd-is-regulated-by-pro-inflammatory-cytokines-and-plays-a-role-in-the-development-of-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology